TDC
CLDX icon

Thompson Davis & Co’s Celldex Therapeutics CLDX Stock Holding History

Thompson Davis & Co’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-467
Closed -$110K – 1084
2015
Q4 		$110K Buy
+467
New +$110K 0.16% 150